Transcatheter Mitral Valve Repair & Replacement Market Growth Analysis By Top Key Players: Abbott Laboratories, Biotronik Pvt Ltd, Colibri Heart Valve, LLC, Edward Lifesciences, HLT Medical, LivaNova Plc, Medtronic Plc and more

The Transcatheter mitral repair and replacement market was valued at $ 324 million (excluding replacement valve sales) in 2016 and is expected to reach $ 1,878 million (both repair and replacement valves) by 2027 and by 30.0% Accounted for the largest share of the entire market in 2016.

The mitral valve is a heart valve that sends blood from one chamber of the heart to the left atrium to another valve called the left ventricle. The mitral valve keeps the blood flow in the right direction and prevents blood from flowing backwards. Failure to provide sufficient blood to the left ventricle will result in valve repair and replacement leading to bacterial endocarditis, congestive heart failure, and sudden death.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/4512?utm_source=sy

The report provides a comprehensive analysis of the key players operating in the global transcatheter mitral valve repair & replacement market such as
• LivaNova Plc
• Abbott Laboratories
• Biotronik Pvt Ltd
• Edward Lifesciences
• Medtronic Plc
• Neovasc Inc.
• NeoChord
• St. Jude Medical
• Direct Flow Medical Inc.
• Colibri Heart Valve LLC.

The other players in the value chain of the global transcatheter mitral valve repair and replacement market include Venus Medtech, HLT Medical, Transcatheter Technologies GmbH, MValve Technologies, Coramaze Technologies GmbH, and Mardil Medical.

Growth in geriatric population and rise in mitral valve disorders drive the market growth. In addition, technological advancements coupled with the introduction novel mitral valves are the other factors that drive the market growth. The major restraint observed for this market is the strict regulations by the governing bodies as well as high cost of mitral valve surgeries and high risk associated with these procedures. Moreover, rise in healthcare expenditure and emergence in developing countries will create lucrative opportunities for key market players.

Make an Enquiry before Buy @ https://www.alliedmarketresearch.com/purchase-enquiry/4512?utm_source=sy

Mitral valve Stenosis application is anticipated to maintain its dominance during the forecast period, owing to the high prevalence of mitral valve stenosis caused by the rheumatic fever, which is an infectious heart disease. This has led to the remarkable demand for the tanscatheter mitral valve repair & replacement devices.

Key Findings of theTranscatheter Mitral Valve Repair and Replacement Market
• The U.S. was the major shareholder in the North America transcatheter mitral valve repair & replacement market, and accounted for the highest share in 2016.
• Bioprosthetic tissue (biological) valves is expected to grow at the significant CAGR of 30.5% during 2017-2023.
• China occupied about one-fourth share of the total Asia-Pacific transcatheter mitral valve repair & replacement market in 2016. Whereas, India is expected to grow rapidly registering a CAGR of 32.9% during the forecast period.
• The mitral valve regurgitation segment is growing at a highest CAGR of 33.5% from 2017 to 2023.
• UK is anticipated to exhibit a highest CAGR during the forecast period.

In 2016, Asia-Pacific and LAMEA collectively accounted for about one-third share of the global transcatheter mitral valve repair & replacement market and is expected to continue this trend throughout the forecast period. Key factors driving the market include the prevalence of mitral valve diseases and deaths caused owing to this disease. Mitral valve diseases are sometimes inoperable and can be treated by performing mitral valve surgeries.

Access Full Summery @ https://www.alliedmarketresearch.com/transcatheter-mitral-valve-repair-and-replacement-market?utm_source=sy

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Contact:

David Correa

5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States

Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975

help@alliedmarketresearch.com

This release was published on openPR.